Try our corporate solution for free!

R&D expenses of Moderna 2016-2021

Published by
Matej Mikulic,
Mar 4, 2022
The statistic illustrates the research and development expenses of Moderna Inc. between 2016 and 2021. Moderna spent two billion U.S. dollars on R&D in 2021, significantly more than in previous years. The firm recently became widely known for being one of two companies worldwide which had their COVID-19 vaccine approved already in late 2020.

Research and development expenses of Moderna Inc. from 2016 to 2021 (in million U.S. dollars)

Loading statistic...

© Statista 2022
You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

Small and medium-sized biotech companiesGlobal pharmaceutical industryBiotech drug industryTop pharmaceutical drugsBiotechnology in Europe
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu